- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer in United Kingdom
Total 24587 results
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); National Institute for Biomedical Imaging...TerminatedStage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma | Bladder Papillary Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial Carcinoma | Stage I Bladder Cancer With Carcinoma In Situ | Stage...United States
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Wellspect HealthCareCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Netherlands, Poland, United Kingdom
-
University of PennsylvaniaCompletedGastric Cancer | Bladder CancerUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, France, Austria, United Kingdom, Israel, Italy, Turkey, Greece, Portugal, Romania
-
Institute of Cancer Research, United KingdomNational Institute for Health Research, United KingdomUnknownBladder CancerUnited Kingdom
-
Cedars-Sinai Medical CenterTerminated
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins University; National Institutes of Health (NIH)WithdrawnBladder Cancer | Urothelial Carcinoma | Bladder TumorUnited States
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
M.D. Anderson Cancer CenterNot yet recruitingAdvanced Bladder CancerUnited States
-
University of ArizonaRecruiting
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen...RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Metastatic Bladder Carcinoma | Urachal Adenocarcinoma | Locally Advanced Bladder Carcinoma | Malignant Renal Pelvis Neoplasm | Malignant Ureter Neoplasm | Malignant Urethral Neoplasm and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage III Renal Cell Cancer | Recurrent Bladder Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
NYU Langone HealthCompletedProstate Cancer | Bladder CancerUnited States
-
Cancer Research UKUnknownLymphoma | Kidney Cancer | Pancreatic Cancer | Esophageal Cancer | Brain and Central Nervous System Tumors | Bladder Cancer | Intraocular Melanoma | Melanoma (Skin) | Transitional Cell Cancer of the Renal Pelvis and UreterUnited Kingdom
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); DSM Nutritional...Active, not recruitingBladder CancerUnited States
-
University of PennsylvaniaCompleted
-
Spectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Animated Dynamics, Inc.UnknownBladder CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Vanderbilt University Medical CenterTerminated
-
University of PittsburghCompletedBladder CancerUnited States
-
NYU Langone HealthSociety of Abdominal RadiologyCompletedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminated
-
Weill Medical College of Cornell UniversityCompletedProstate Cancer | Bladder CancerUnited States
-
North Bristol NHS TrustUniversity of Sheffield; University of Bristol; Newcastle University; University... and other collaboratorsUnknownLower Urinary Tract Symptoms | Voiding Dysfunction | Detrusor Underactivity | Benign Prostate ObstructionUnited Kingdom
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Spectrum Pharmaceuticals, IncTerminated
-
Ohio State University Comprehensive Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminatedBladder CancerUnited States
-
Stanford UniversitySanofi-SynthelaboCompletedBladder CancerUnited States
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
Dana-Farber Cancer InstitutePfizerRecruitingBladder Cancer | Muscle Invasive Bladder CancerUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Wake Forest University Health SciencesUniversity of MiamiTerminatedBladder CancerUnited States
-
The University of Texas Health Science Center at...CompletedBladder CancerUnited States
-
University of Kansas Medical CenterUniversity of KansasCompletedBladder CancerUnited States
-
University of Southern CaliforniaCompleted
-
University of RochesterAstellas Pharma IncTerminated